Dr Valeria T Martinez-kaigi, PHD, MS | |
300 Post Rd W, Westport, CT 06880-4703 | |
(203) 226-2499 | |
Not Available |
Full Name | Dr Valeria T Martinez-kaigi |
---|---|
Gender | Female |
Speciality | Clinical Psychologist |
Experience | 6 Years |
Location | 300 Post Rd W, Westport, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013510114 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TH0004X | Psychologist - Health | 003983 (Connecticut) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Merion Square Road Medical Pc | 0446605422 | 5 |
News Archive
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
A new study of Tourette syndrome (TS) led by researchers from UC San Francisco and Massachusetts General Hospital has found that nearly 86 percent of patients who seek treatment for TS will be diagnosed with a second psychiatric disorder during their lifetimes, and that nearly 58 percent will receive two or more such diagnoses.
President Barack Obama's budget plan includes a two-year Medicare "doc-fix" that uses heavy cuts in other health providers' Medicare reimbursements to stave-off a scheduled 25 percent reduction in Medicare physician reimbursements. Meanwhile, news outlets also report the plan "avoids" tackling entitlement spending.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the publication of a case report in the peer-reviewed Journal of Clinical Oncology documenting the use of tamibarotene in the successful treatment of a patient with recurrent advanced-stage acute promyelocytic leukemia.
University of Washington researchers have made a discovery that sheds light on why the human body is unable to adequately fight off HIV infection.
› Verified 2 days ago
Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
A new study of Tourette syndrome (TS) led by researchers from UC San Francisco and Massachusetts General Hospital has found that nearly 86 percent of patients who seek treatment for TS will be diagnosed with a second psychiatric disorder during their lifetimes, and that nearly 58 percent will receive two or more such diagnoses.
President Barack Obama's budget plan includes a two-year Medicare "doc-fix" that uses heavy cuts in other health providers' Medicare reimbursements to stave-off a scheduled 25 percent reduction in Medicare physician reimbursements. Meanwhile, news outlets also report the plan "avoids" tackling entitlement spending.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the publication of a case report in the peer-reviewed Journal of Clinical Oncology documenting the use of tamibarotene in the successful treatment of a patient with recurrent advanced-stage acute promyelocytic leukemia.
University of Washington researchers have made a discovery that sheds light on why the human body is unable to adequately fight off HIV infection.
› Verified 2 days ago
Entity Name | Merion Square Road Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942923123 PECOS PAC ID: 0446605422 Enrollment ID: O20231013002390 |
News Archive
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
A new study of Tourette syndrome (TS) led by researchers from UC San Francisco and Massachusetts General Hospital has found that nearly 86 percent of patients who seek treatment for TS will be diagnosed with a second psychiatric disorder during their lifetimes, and that nearly 58 percent will receive two or more such diagnoses.
President Barack Obama's budget plan includes a two-year Medicare "doc-fix" that uses heavy cuts in other health providers' Medicare reimbursements to stave-off a scheduled 25 percent reduction in Medicare physician reimbursements. Meanwhile, news outlets also report the plan "avoids" tackling entitlement spending.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the publication of a case report in the peer-reviewed Journal of Clinical Oncology documenting the use of tamibarotene in the successful treatment of a patient with recurrent advanced-stage acute promyelocytic leukemia.
University of Washington researchers have made a discovery that sheds light on why the human body is unable to adequately fight off HIV infection.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Valeria T Martinez-kaigi, PHD, MS 300 Post Rd W Fl 1, Westport, CT 06880-4703 Ph: (203) 332-3272 | Dr Valeria T Martinez-kaigi, PHD, MS 300 Post Rd W, Westport, CT 06880-4703 Ph: (203) 226-2499 |
News Archive
Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
A new study of Tourette syndrome (TS) led by researchers from UC San Francisco and Massachusetts General Hospital has found that nearly 86 percent of patients who seek treatment for TS will be diagnosed with a second psychiatric disorder during their lifetimes, and that nearly 58 percent will receive two or more such diagnoses.
President Barack Obama's budget plan includes a two-year Medicare "doc-fix" that uses heavy cuts in other health providers' Medicare reimbursements to stave-off a scheduled 25 percent reduction in Medicare physician reimbursements. Meanwhile, news outlets also report the plan "avoids" tackling entitlement spending.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the publication of a case report in the peer-reviewed Journal of Clinical Oncology documenting the use of tamibarotene in the successful treatment of a patient with recurrent advanced-stage acute promyelocytic leukemia.
University of Washington researchers have made a discovery that sheds light on why the human body is unable to adequately fight off HIV infection.
› Verified 2 days ago
Dr. Cindy R. Scope, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 19 Compo Rd S, Westport, CT 06880 Phone: 203-652-7722 | |
Dr. Annalise Lawler Caron, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1720 Post Rd E Ste 223, Westport, CT 06880 Phone: 203-220-6486 Fax: 203-220-6487 | |
Alison Bellevue, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1720 Post Rd E, Suite 223, Westport, CT 06880 Phone: 203-220-6486 | |
Dr. Stephanie Gail Ehrman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 215 Main St, Westport, CT 06880 Phone: 917-453-1250 Fax: 203-454-2447 | |
Dr. Vanessa Camille Weinbach, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6 Riverfield Dr, Westport, CT 06880 Phone: 203-343-4208 Fax: 203-350-8286 | |
Dr. Amanda Jean Letard, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1720 Post Rd E, Suite 223, Westport, CT 06880 Phone: 203-220-6486 Fax: 203-220-6486 |